Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
|Format:||Government Document Online Book|
U.S. Government Publishing Office,
|Online Access:||ONLINE VERSION|
No Tags, Be the first to tag this record!